Telo Genomics Corp.
OTC: TDSGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- John Allen Farlinger
- Employees
- 8
- Headquarters
- Toronto, Canada
- IPO year
- 2021
- Market cap
- $3.1M
- Website
- https://www.telodx.com
Loading TDSGF…
Loading profile data…Frequently asked questions about TDSGF
What does Telo Genomics Corp. (TDSGF) do?
Telo Genomics Corp. is a biotechnology enterprise focused on developing and commercializing sophisticated predictive technologies. Their mission is to enable personalized treatment approaches for patients facing specific health challenges. The company's central offering is a telomere analysis platform, which provides both diagnostic insights and...
Where does TDSGF trade?
Telo Genomics Corp. (TDSGF) trades on the Other OTC.
What sector is TDSGF in?
Telo Genomics Corp. (TDSGF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Telo Genomics Corp.?
John Allen Farlinger is the chief executive officer of Telo Genomics Corp. (TDSGF).
Where is Telo Genomics Corp. headquartered?
Telo Genomics Corp. is headquartered in Canada.
Does TDSGF pay a dividend?
Telo Genomics Corp. (TDSGF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TDSGF go public?
Telo Genomics Corp. (TDSGF) completed its initial public offering in 2021.